Musculoskeletal

Best Peptides for Tendinopathy: Evidence-Based Guide

Independent guide to peptides for tendinopathy and tendon injuries. BPC-157 and TB-500 compared with evidence, dosing, and protocols.

Affects approximately 30% of active adults; one of the most common sports injuries

This page is for educational purposes only and does not constitute medical advice. Peptides discussed are research compounds. Always consult a qualified healthcare provider for diagnosis and treatment.

Understanding Tendinopathy (Tendon Injury)

Tendinopathy encompasses a spectrum of tendon disorders including tendinitis (acute inflammation) and tendinosis (chronic degeneration). Common sites include the Achilles, patellar, rotator cuff, and lateral epicondyle tendons. Standard treatment includes rest, physical therapy, NSAIDs, and corticosteroid injections — but outcomes are often incomplete, driving interest in regenerative approaches.

Common Symptoms

Localized tendon pain, especially with loading

Morning stiffness that improves with activity

Tendon thickening or nodularity

Reduced strength and range of motion

Pain that worsens with repetitive activity

Conventional Treatments

Rest and activity modificationEccentric exercise protocolsNSAIDs (short-term)Corticosteroid injections (short-term relief)Platelet-rich plasma (PRP) injectionsSurgery (severe cases)

How Peptides May Help

BPC-157 has demonstrated direct tendon healing effects in multiple animal studies, including upregulation of growth factor receptors (VEGFR2, FGFR2), promotion of angiogenesis, and acceleration of tendon-to-bone healing. TB-500 promotes cell migration and actin polymerization, supporting the repair of tendon fibers. Together, they address the vascular and structural components of tendon healing.

Top Peptides for Tendinopathy (Tendon Injury)

1BPC-157

Strong preclinical; limited human data

Mechanism: Upregulates growth factor receptors, promotes angiogenesis, accelerates tendon-to-bone healing

Typical dose: 250-500mcg SubQ near injury site, twice daily

2TB-500

Moderate preclinical

Mechanism: Promotes cell migration and actin polymerization; systemic tissue repair

Typical dose: 5-10mg/week loading, 2.5-5mg/week maintenance

Suggested Starting Protocol

Loading phase (weeks 1-4): BPC-157 500mcg twice daily + TB-500 5mg twice weekly. Maintenance (weeks 5-12): BPC-157 250mcg once daily + TB-500 2.5mg twice weekly. Combine with eccentric exercise protocol.

Important: Peptide research for tendinopathy is primarily preclinical (animal studies). Human clinical trials are limited. These compounds are research chemicals, not FDA-approved treatments. Consult a sports medicine physician for severe tendon injuries.

Frequently Asked Questions

How long does BPC-157 take to heal tendons?

Most users report noticeable pain reduction and functional improvement within 2-4 weeks of the loading phase. Complete tendon healing typically takes 8-12 weeks of consistent use combined with appropriate physical therapy.

Can I inject BPC-157 directly into the tendon?

Inject into the subcutaneous tissue near the tendon, not directly into the tendon itself. Intra-tendinous injection requires medical training and carries risk of tendon rupture.

Is BPC-157 better than PRP for tendinopathy?

No direct comparison studies exist. PRP has more human clinical evidence; BPC-157 has stronger preclinical mechanistic data. Some practitioners use both together.

Related Conditions

sports injury muscle recovery back pain rotator cuff

Find the right peptide for your biology

Take our 5-minute quiz to get a personalized peptide recommendation based on your specific goals and health profile.